Skip to content

PHARMASENSE

Active Risk: not assessed Private limited companyfounded 2010active for 16 yearsHeibergstraat 17, 2222 Heist-op-den-BergKBO/BCE: BE 0827.039.024

Lifetime

16 annual accounts with figures on one time axis
peak of €243,670 in 2025
€243,670▲ 3.9%
peak of €157,945 in 2025
€157,945▲ 6.0%
peak of €1.3m in 2025
€1.3m▲ 14.4%
€674,451▼ 19.5%
Board2 names since 2021
2 directors and 1 other
Documentsfilings and deeds
28-08-202628 days late
2025micro format
Equity from €1.1m to €1.3mDebts from €838,030 to €674,451Investments €18,480Cash from €68,426 to €5

Key points

from the 2025 annual accounts

Equity

€1.3m ▲ 14.4%

PHARMASENSE has made a profit in every financial year since 2010.

Investments

€18,480 10.6 times depreciation

Green is investment, beige is depreciation.

Filings

16 annual accounts since 2010
AprilJune31 JulyOctober2010201520202025

Six of the last ten came late. The 2017 accounts came in latest, 31 days after the end of the period.

Checked score

Outside the general model
Model not applicable to financial institutions
The Checked score measures liquidity, leverage and margins against the norms for trading and manufacturing companies. A bank, insurer or financial holding has a very different balance sheet. Those ratios and the score mean nothing here. So there is no financial strength either.

Bankruptcy probability within 12 months

The company is a financial institution: a bank, insurer or financial holding. Its balance sheet works differently from that of a trading or manufacturing company. A bankruptcy probability from the general model would mislead here.

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director
Director

Shares in 1 company,

Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0827039024
2 managers resigning, 2 directors reappointed (manager) and (manager) resign · (director) and (director) reappointed · Gazette deed
acts as permanent representative General meeting of 11-01-2019 · Gazette deed
First establishment Heibergstraat 17, Heist-op-den-Berg
All 27 events

Comparable companies

same main activity, similar in size and age
Company
PHARMASENSE Heist-op-den-Berg €1.9m €243,670 65.1% -
HANDIRI HOLDING Antwerp €2.2m €252,012 20.2% 0
CHRILIE Vorselaar €2.2m €253,148 79.3% -
YVG Brasschaat €2.0m €205,946 13.6% 0.8
PAUWLUS Antwerp €1.6m €210,399 41.9% -
INVENTYS Aartselaar €1.6m €269,487 43.3% 1
W. ARNOUTS Mechelen €1.8m €298,043 44.6% -

These companies have the same main activity as PHARMASENSE: activities of holding companies (NACE 64210). They are comparable in size and age: total assets between €1.6m and €2.2m, founded between 2008 and 2011.

Official details

Source: KBO
Status
Active since 25-06-2010Normal situation
Activity
Activities of holding companiesNACE 64210and 1 other
Establishment unit
2.189.512.8032222 Heist-op-den-Berg, since 29-06-2010
Financial year end
31 December
Peppol
Reachable since 29-04-2025
Company details

Annual accounts 2025

€1.9m▼ 0.3%
Filing
Filed on 28-08-2026
Financials

Insights on PHARMASENSE

PHARMASENSE files the micro format. That format states no turnover. The gross margin rose from €59,873 in 2010 to €243,670 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about PHARMASENSE

What is the company number of PHARMASENSE?
The company number of PHARMASENSE is 0827.039.024. The VAT number is the same number with BE in front: BE 0827.039.024.
Where is PHARMASENSE based?
The registered office is at Heibergstraat 17, 2222 Heist-op-den-Berg.Company details
What does PHARMASENSE do?
According to the KBO register, the main activity is activities of holding companies (NACE 64210).
What is the legal form of PHARMASENSE?
PHARMASENSE is a private limited company (BV).
When was PHARMASENSE founded?
PHARMASENSE was founded on 25-06-2010.
Is PHARMASENSE still active?
Yes, PHARMASENSE is an active enterprise in the KBO register.
What is the turnover of PHARMASENSE?
The turnover in financial year 2025 is ≈ €380,000. This figure is estimated from the gross margin of €243,670 and 34 comparable companies (NACE 64210). It probably lies between €320,000 and €470,000.Financials
Is PHARMASENSE profitable?
In financial year 2025, PHARMASENSE made a profit of €157,945.
Where can I find the annual accounts of PHARMASENSE?
PHARMASENSE filed 16 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of PHARMASENSE due?
PHARMASENSE must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.